Recherches "plusieurs pathologies" DERMACLIC (IC 2019-12) Study on skin toxicities induced by cancer treatments Paris
Appareil pulmonaire FDG-Immun Cohort Study Evaluating 18FDG PET for Early Identification of Tumor Exhaust for Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Bronchopulmonary Carcinoma or Melanoma Paris MARIE LUPORSI
Appareil pulmonaire CA224-104 (RELATIVITY) A Phase 2 Randomized Double-blind Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) Paris NICOLAS GIRARD
Sein Néoadjuvant ROSALINE Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast Paris FLORENCE COUSSY
VADS MK7902-009 (LEAP-009) Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009) Paris CHRISTOPHE LE TOURNEAU
Sein Néoadjuvant Neo-CheckRay Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: a Phase ll Randomised Trial. Paris EMANUELA ROMANO
Recherches "plusieurs pathologies" BRAINSTORM A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours - BrainStorm Program Paris
Appareil pulmonaire LIST CA209-7HX A Multi-Center, Longitudinal, Prospective, Observational, Multi-Cohort Study of Patients;with Advanced Non-Small Cell Lung Cancer treated with nivolumab in France after at least;one prior chemotherapy-based treatment (LIST, Lung Initiative on Sequence Therapy) Paris CATHERINE DANIEL